Physician profile
Balkrishna M Singh
NPI 1639125222
$1,980.48
in general payments reported to CMS, 2019-2025
17 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $229 · 2021: $414 · 2022: $359 · 2023: $165 · 2024: $258 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $985.64 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $268.80 | 2023-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $207.21 | 2021-2022 | |
| Boston Scientific Corporation | $102.61 | 2019-2022 | |
| Novo Nordisk INC | $93.64 | 2025 | Wegovy |
| Pfizer INC. | $56.58 | 2021-2022 | |
| Baxter Healthcare | $55.55 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Abbott Laboratories | $44.75 | 2021-2022 | |
| Irhythm Technologies, INC. | $36.19 | 2024 | Zio Xt Patch, Zio Monitor |
| Alnylam Pharmaceuticals INC. | $19.21 | 2022 | |
| Edwards Lifesciences Corporation | $19.00 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.74 | 2023 | Lifevest |
| Philips North America LLC | $16.52 | 2020 | |
| Abiomed | $15.07 | 2020 | |
| Merck Sharp & Dohme LLC | $15.07 | 2024 | Verquvo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $14.26 | 2020 | |
| Amgen INC. | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Balkrishna Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.